Noninvasive screening by cell-free DNA for 22q11.2 deletion: Benefits, limitations, and challenges.
Saved in:
| Title: | Noninvasive screening by cell-free DNA for 22q11.2 deletion: Benefits, limitations, and challenges. |
|---|---|
| Authors: | Grati FR; Research and Development, Cytogenetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A., Busto Arsizio (Varese), Italy., Gross SJ; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. |
| Source: | Prenatal diagnosis [Prenat Diagn] 2019 Jan; Vol. 39 (2), pp. 70-80. Date of Electronic Publication: 2019 Jan 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 8106540 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0223 (Electronic) Linking ISSN: 01973851 NLM ISO Abbreviation: Prenat Diagn |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0223 |
|---|---|
| DOI: | 10.1002/pd.5391 |
